{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:18:55Z","timestamp":1791195535076,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1038\/s41379-018-0165-9","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T03:42:37Z","timestamp":1541475757000},"page":"490-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Hematopoietic neoplasms with 9p24\/JAK2 rearrangement: a multicenter study"],"prefix":"10.1016","volume":"32","author":[{"given":"Guilin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Kennedy","family":"Sydney Sir Philip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Sadigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8597-0636","authenticated-orcid":false,"given":"Elizabeth M.","family":"Margolskee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heesun J.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Bueso-Ramos C","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Hasserjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Arber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-018-0165-9_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gde.2006.12.009","article-title":"Jak2: normal function and role in hematopoietic disorders","volume":"17","author":"Ihle","year":"2007","journal-title":"Curr Opin Genet Dev"},{"key":"10.1038\/s41379-018-0165-9_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.blre.2010.10.004","article-title":"JAK2 inhibitors: what's the true therapeutic potential?","volume":"25","author":"Santos","year":"2011","journal-title":"Blood Rev"},{"key":"10.1038\/s41379-018-0165-9_bib3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/bjh.12963","article-title":"Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?","volume":"166","author":"Bain","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1038\/s41379-018-0165-9_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajh.2830340113","article-title":"Neutrophilic myelofibrosis presenting as Philadelphia chromosome negative BCR non-rearranged chronic myeloid leukemia","volume":"34","author":"Stewart","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1038\/s41379-018-0165-9_bib5","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1158\/0008-5472.CAN-04-4263","article-title":"The t(8;9)(p22; p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2","volume":"65","author":"Reiter","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-018-0165-9_bib6","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00277-015-2451-7","article-title":"Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene","volume":"94","author":"Rumi","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1038\/s41379-018-0165-9_bib7","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Revised","first-page":"72","article-title":"Myeloid\/lymphoid neoplasms with eosinophilia and rearrangements of PDGFRAPDGFRB or FGFR1, or with PCM1-JAK2","author":"Bain","year":"2017"},{"key":"10.1038\/s41379-018-0165-9_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1309\/AJCPBADO22WXOFHJ","article-title":"Isolated del(5q) in patients following therapies for various malignancies may not all be clinically significant","volume":"144","author":"Tang","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-018-0165-9_bib9","first-page":"1128","article-title":"European consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"key":"10.1038\/s41379-018-0165-9_bib10","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/modpathol.2016.75","article-title":"Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified","volume":"29","author":"Wang","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0165-9_bib11","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3324\/haematol.2017.165340","article-title":"Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome","volume":"102","author":"Wang","year":"2017","journal-title":"Haematologica"},{"key":"10.1038\/s41379-018-0165-9_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00277-014-2221-y","article-title":"Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes","volume":"94","author":"Schwaab","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1038\/s41379-018-0165-9_bib13","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1200\/JCO.2012.46.4370","article-title":"Efficacy of ruxolitinib in chronic eosinophilic leukemia associated with a PCM1-JAK2 fusion gene","volume":"31","author":"Rumi","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-018-0165-9_bib14","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/sj.leu.2403879","article-title":"PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation","volume":"19","author":"Murati","year":"2005","journal-title":"Leukemia"},{"key":"10.1038\/s41379-018-0165-9_bib15","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1038\/sj.onc.1208850","article-title":"The t(8;9)(p22; p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene","volume":"24","author":"Bousquet","year":"2005","journal-title":"Oncogene"},{"key":"10.1038\/s41379-018-0165-9_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00277-017-3211-7","article-title":"Bone marrow findings in blast phase of polycythemia vera","volume":"97","author":"Hidalgo Lopez","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1038\/s41379-018-0165-9_bib17","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood.V90.7.2535","article-title":"Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia","volume":"90","author":"Peeters","year":"1997","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0165-9_bib18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00277-012-1431-4","article-title":"Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia","volume":"91","author":"Zhou","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1038\/s41379-018-0165-9_bib19","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.leukres.2010.05.031","article-title":"Novel JAK2 rearrangement resulting from a t(9;22)(p24; q11.2) in B-acute lymphoblastic leukemia","volume":"34","author":"Tirado","year":"2010","journal-title":"Leuk Res"},{"key":"10.1038\/s41379-018-0165-9_bib20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","article-title":"High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults","volume":"35","author":"Roberts","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-018-0165-9_bib21","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/blood-2016-12-758979","article-title":"Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group","volume":"129","author":"Reshmi","year":"2017","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0165-9_bib22","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-018-0165-9_bib23","series-title":"WHO classification of Tumors of Haematopoietic and Lymphoid Tissue","article-title":"B-lymphoblasticleukemia\/lymphoma with recurrent genetic abnormalities","author":"Borowitz","year":"2017"},{"key":"10.1038\/s41379-018-0165-9_bib24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2141.2008.07480.x","article-title":"Myeloid and lymphoid neoplasm with FGFR1 abnormality","volume":"145","author":"Keane","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1038\/s41379-018-0165-9_bib25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.6004\/jnccn.2016.0072","article-title":"Cytogenetic Evolution Associated With Disease Progression in Hematopoietic Neoplasms With t(8;22)(p11; q11)\/BCR-FGFR1 Rearrangement","volume":"14","author":"Wang","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1038\/s41379-018-0165-9_bib26","doi-asserted-by":"crossref","unstructured":"Baer C, Muehlbacher V, Kern W, Haferlach C, Haferlach T. Molecular genetic characterization of myeloid\/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2. Haematologica. 2018.","DOI":"10.3324\/haematol.2017.187302"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0165-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0165-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222014582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222014582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0165-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:49:45Z","timestamp":1760230185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222014582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0893395222014582"],"URL":"https:\/\/doi.org\/10.1038\/s41379-018-0165-9","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic neoplasms with 9p24\/JAK2 rearrangement: a multicenter study","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-018-0165-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}